ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.493
-0.037 (-7.00%)
At close: Jan 21, 2025, 4:00 PM
0.630
+0.137 (27.79%)
After-hours: Jan 21, 2025, 7:59 PM EST
ImmunoPrecise Antibodies Employees
As of April 30, 2024, ImmunoPrecise Antibodies had 101 total employees, including 72 full-time and 29 part-time employees. The number of employees decreased by 1 or -0.98% compared to the previous year.
Employees
101
Change (1Y)
-1
Growth (1Y)
-0.98%
Revenue / Employee
$171,013
Profits / Employee
-$198,247
Market Cap
16.53M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 101 | -1 | -0.98% |
Apr 30, 2023 | 102 | 17 | 20.00% |
Apr 30, 2022 | 85 | 12 | 16.44% |
Apr 30, 2021 | 73 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
IPA News
- 4 days ago - ImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation - Business Wire
- 21 days ago - IPA Announces Resignation of Chief Financial Officer - Business Wire
- 22 days ago - $116 Million Multifamily Asset Sale in Central California Coast Region Brokered by Marcus & Millichap's Institutional Property Advisors - Business Wire
- 4 weeks ago - ImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share Purchases - Business Wire
- 4 weeks ago - IPA to Present at The Microcap Conference 2025 - Accesswire
- 6 weeks ago - ImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 - Business Wire
- 6 weeks ago - IPA to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - Business Wire